diabetic retinopathy

With artificial intelligence in health care on the rise, eye screenings for diabetic retinopathy are emerging as one of the first proven use cases of AI-based diagnostics in a clinical setting.

Americans think losing their eyesight would be one of the worst possible health outcomes, yet millions lack a fundamental understanding of eye health.

Diabetes is the leading cause of vision loss among working-age adults and is more common in low-income neighborhoods and people of color.

Software that can replace doctors for certain tasks has a big responsibility. The Food and Drug Administration is now figuring out how to determine when computer algorithms are safe and effective.